EarningsQ3 2024 Earnings Report

Resmed (RMD) Q3 2024 Earnings Report

2 Followers

MX:RMD Q3 2024 EPS Results

Actual EPS$38.72

Consensus EPS$35.03

Beat/MissBeat by +$3.69

One Year Ago EPS$30.54

Actual Revenue$21.76B

Expected Revenue$21.34B

Beat/MissBeat by +$414.35M

YoY Revenue Growth+7.17%

QuarterQ3 2024

Date04/25/2024

TimeAfter Close

Conference CallThursday, April 25, 2024

MX:RMD Upcoming Earnings

Resmed's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:RMD Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2027 (Q1)	48.74 / -	46.354	―
Aug 06, 2026	2026 (Q4)	52.59 / 53.63	46.354	15.69% (+7.27)
Apr 30, 2026	2026 (Q3)	50.81 / 51.99	43.082	20.68% (+8.91)
Jan 29, 2026	2026 (Q2)	49.90 / 51.08	44.173	15.64% (+6.91)
Oct 30, 2025	2026 (Q1)	45.75 / 46.35	39.992	15.91% (+6.36)
Jul 31, 2025	2025 (Q4)	45.30 / 46.35	37.811	22.60% (+8.54)
Apr 23, 2025	2025 (Q3)	43.23 / 43.08	38.72	11.27% (+4.36)
Jan 30, 2025	2025 (Q2)	42.10 / 44.17	34.175	29.26% (+10.00)
Oct 24, 2024	2025 (Q1)	37.34 / 39.99	29.812	34.15% (+10.18)
Aug 01, 2024	2024 (Q4)	37.87 / 37.81	29.085	30.00% (+8.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed